Asbestos-Induced Autoimmunity in C57Bl/6 Mice

REFERENCES

• Bagavant H., Deshmukh U. S., Gaskin F., Fu S. M. Lupus glomerulonephritis revisited 2004: Autoimmunity and end-organ damage. Scand. J. Immunol. 2004; 60: 52–63
   PubMedGoogle Scholar
• Bassett W. A. The origin of the vermiculite deposit at Libby, Montana. Am. Mineralogist 1959; 44: 282–299
   Web of Science ®Google Scholar
• Brown J. M., Archer A. J., Pfau J. C., Holian A. Silica accelerated systemic autoimmune disease in lupus-prone New Zealand mixed mice. Clin. Exp. Immunol. 2003; 131: 415–421
   PubMed Web of Science ®Google Scholar
• Brown J. M., Pfau J. C., Holian A. Immunoglobulin and lymphocyte responses following silica exposure in New Zealand mixed mice. Inhal. Toxicol. 2004a; 16: 133–139
   PubMed Web of Science ®Google Scholar
• Brown J. M., Pfau J. C., Pershouse M. A., Holian A. Silica, apoptosis, and autoimmunity. J. Immunotoxicol. 2004b; 1: 177–187
   Google Scholar
• Casciola-Rosen L. A., Anhalt G., Rosen A. Autoantigens targeted in systemic lupus erythematosus are clustered in two populations of surface structures on apoptotic keratinocytes. J. Exp. Med. 1994; 179: 1317–1330
   PubMed Web of Science ®Google Scholar
• Chatenoud L., Salomon B., Bluestone J. A. Suppressor T-cells–they're back and critical for regulation of autoimmunity!. Immunol. Rev. 2001; 182: 149–163
   PubMed Web of Science ®Google Scholar
• Davis G. S., Leslie K. O., Hemenway D. R. Silicosis in mice: Effects of dose, time, and genetic strain. J. Environ. Pathol. Toxicol. Oncol. 1998; 17: 81–97
   PubMedGoogle Scholar
• Fattman C. L., Tan R. J., Tobolewski J. M., Oury T. D. Increased sensitivity to asbestos-induced lung injury in mice lacking extracellular superoxide dismutase. Free Rad. Biol. Med. 2006; 40: 601–607
   PubMed Web of Science ®Google Scholar
• Gharaee-Kermani M., Ullenbruch M., Phan S. H. Animal models of pulmonary fibrosis. Meth. Mol. Med. 2005; 117: 251–259
   PubMedGoogle Scholar
• Hall J. C., Casciola-Rosen L., Rosen A. Altered structure of autoantigens during apoptosis. Rheum. Dis. Clin. North Am. 2004; 30: 455–471, vii
   PubMed Web of Science ®Google Scholar
• Hamilton R. F., Iyer L. L., Holian A. Asbestos induces apoptosis in human alveolar macrophages. Am. J. Physiol 1996; 271(5)L813–L819, Pt 1
   PubMedGoogle Scholar
• Hillion S., Rochas C., Youinou P., Jamin C. Expression and re-expression of recombination activating genes: Relevance to the development of autoimmune states. Ann. N. Y. Acad. Sci. 2005; 1050: 10–18
   PubMedGoogle Scholar
• Hudson C. A., Cao L., Kasten-Jolly J., Kirkwood J. N., Lawrence D. A. Susceptibility of lupus-prone NZM mouse strains to lead exacerbation of systemic lupus erythematosus symptoms. J. Toxicol. Environ. Health A 2003; 66: 895–918
   PubMed Web of Science ®Google Scholar
• Huggins M. L., Todd I., Cavers M. A., Pavuluri S. R., Tighe P. J., Powell R. J. Antibodies from systemic lupus erythematosus (SLE) sera define differential release of autoantigens from cell lines undergoing apoptosis. Clin. Exp. Immunol. 1999; 118: 322–328
   PubMedGoogle Scholar
• Ishii T., Ohnuma K., Murakami A., Takasawa N., Yamochi T., Iwata S., Uchiyama M., Dang N. H., Tanaka H., Morimoto C. SS-A/Ro52, an autoantigen involved in CD28-mediated IL-2 production. J. Immunol. 2003; 170: 3653–3661
   PubMedGoogle Scholar
• Karachunski P. I., Ostlie N. S., Monfardini C., Conti-Fine B. M. Absence of IFN-γ or IL-12 has different effects on experimental myasthenia gravis in C57BL/6 mice. J. Immunol. 2000; 164: 5236–5244
   PubMedGoogle Scholar
• Koeger A. C., Lang T., Alcaix D., Milleron B., Rozenberg S., Chaibi P., Arnaud J., Mayaud C., Camus J. P., Bourgeois P. Silica-associated connective tissue disease. A study of 24 cases. Medicine (Baltimore) 1995; 74: 221–237
   PubMed Web of Science ®Google Scholar
• Lange A. An epidemiological survey of immunological abnormalities in asbestos workers. II. Serum immunoglobulin levels. Environ. Res. 1980; 22: 176–183
   PubMedGoogle Scholar
• Latham K. A., Zamora A., Drought H., Subramanian S., Matejuk A., Offner H., Rosloniec E. F. Estradiol treatment redirects the isotype of the autoantibody response and prevents the development of autoimmune arthritis. J. Immunol. 2003; 171: 5820–5827
   PubMed Web of Science ®Google Scholar
• Martin R. M., Brady J. L., Lew A. M. The need for IgG2c-specific antiserum when isotyping antibodies from C57BL/6 and NOD mice. J. Immunol. Meth. 1998; 212: 187–192
   PubMedGoogle Scholar
• Meeker G. P., Bern A. M., Brownfield I. K., Lowers H. A., Sutley S. J., Hoefen T. M., Vance J. S. The composition and morphology of amphiboles from the Rainy Creek Complex, near Libby, Montana. Am. Mineralogist 2003; 88: 1955–1969
   Web of Science ®Google Scholar
• Mohan C., Morel L., Yang P., Wakeland E. K. Accumulation of splenic B1a cells with potent antigen-presenting capability in NZM2410 lupus-prone mice. Arthritis Rheum. 1998; 41: 1652–1662
   PubMed Web of Science ®Google Scholar
• Morbach H., Singh S. K., Faber C., Lipsky P. E., Girschick H. H. J. Analysis of RAG expression by peripheral blood CD5+ and CD5- B-cells of patients with childhood systemic lupus erythematosus. Ann. Rheum. Dis. 2006; 65: 482–487
   PubMed Web of Science ®Google Scholar
• Nigam S. K., Suthar A. M., Patel M. M., Karnik A. B., Dave S. K., Kashyap S. K., Venkaiah K. Humoral immunological profile of workers exposed to asbestos in asbestos mines. Indian J. Med. Res. 1993; 98: 274–277
   PubMed Web of Science ®Google Scholar
• Niklinski J., Niklinska W., Chyczewska E., Laudanski J., Naumnik W., Chyczewski L., Pluygers E. The epidemiology of asbestos-related diseases. Lung Cancer 2004; 45(Suppl 1)S7–S15
   PubMedGoogle Scholar
• Noonan C. W., Pfau J. C., Spence M., Larson T. C. Nested case-control study of autoimmune disease in an asbestos-exposed population. Environ. Health Perspect. 2006, On-line ehp.9203
   PubMedGoogle Scholar
• Peene I., Meheus L., De Keyser S., Humbel R., Veys E. M., De Keyser F. Anti-Ro52 reactivity is an independent and additional serum marker in connective tissue disease. Ann. Rheum. Dis. 2002; 61: 929–933
   PubMed Web of Science ®Google Scholar
• Peipins L. A., Lewin M., Campolucci S., Lybarger J. A., Miller A., Middleton D., Weis C., Spence M., Black B., Kapil V. Radiographic abnormalities and exposure to asbestos-contaminated vermiculite in the community of Libby, Montana, USA. Environ. Health Perspect. 2003; 111: 1753–1759
   PubMed Web of Science ®Google Scholar
• Pfau J. C., Brown J. M., Holian A. Silica-exposed mice generate autoantibodies to apoptotic cells. Toxicology 2004; 195: 167–176
   PubMed Web of Science ®Google Scholar
• Pfau J. C., Sentissi J. J., Brown J. M., Thompson R. Asbestos-induced autoimmunity in C57BL/6 mice. The Toxicologist 2005a; 79: 186
   Google Scholar
• Pfau J. C., Sentissi J. J., Weller G., Putnam E. A. Assessment of autoimmune responses associated with asbestos exposure in Libby, Montana, USA. Environ. Health Perspect. 2005b; 113: 25–30
   PubMed Web of Science ®Google Scholar
• Powell J. J., Van de Water J., Gershwin M. E. Evidence for the role of environmental agents in the initiation or progression of autoimmune conditions. Environ. Health Perspect. 1999; 107(Suppl 5)667–672
   PubMedGoogle Scholar
• Putnam E. A., Smartt A., Brezinski M., Groves A., Schwanke C. M., Pershouse M. A. Histologic and gene expression changes after amphibole exposures in a mouse model. J. Immunotoxicol. 2008, In Press
   Google Scholar
• Rudofsky U. H., Lawrence D. A. New Zealand mixed mice: A genetic systemic lupus erythematosus model for assessing environmental effects. Environ. Health Perspect 1999; 107(Suppl 5)713–721
   PubMed Web of Science ®Google Scholar
• Sakaguchi S., Sakaguchi N., Asano M., Itoh M., Toda M. Immunologic self-tolerance maintained by activated T-cells expressing IL-2 receptor α -chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J. Immunol. 1995; 155: 1151–1164
   PubMed Web of Science ®Google Scholar
• Shevach E. M. Regulatory T-cells in autoimmmunity. Annu. Rev. Immunol. 2000; 18: 423–449
   PubMed Web of Science ®Google Scholar
• Shukla A., Stern M., Lounsbury K. M., Flanders T., Mossman B. T. Asbestos-induced apoptosis is protein kinase C delta-dependent. Am. J. Respir. Cell Mol. Biol. 2003; 29: 198–205
   PubMed Web of Science ®Google Scholar
• Stall A. M., Wells S. M., Lam K. P. B-1 cells: Unique origins and functions. Sem. Immunol. 1996; 8: 45–59
   PubMedGoogle Scholar
• Steenland K., Goldsmith D. F. Silica exposure and autoimmune diseases. Am. J. Ind. Med. 1995; 28: 603–608
   PubMed Web of Science ®Google Scholar
• van Nieuwenhuijze A. E., van Lopik T., Smeenk R. J., Aarden L. A. Time between onset of apoptosis and release of nucleosomes from apoptotic cells: Putative implications for systemic lupus erythematosus. Ann. Rheum. Dis. 2003; 62: 10–14
   PubMed Web of Science ®Google Scholar
• Warshamana G. S., Pociask D. A., Sime P., Schwartz D. A., Brody A. R. Susceptibility to asbestos-induced and transforming growth factor-beta1-induced fibroproliferative lung disease in two strains of mice. Am. J. Respir. Cell Mol. Biol. 2002; 27: 705–713
   PubMed Web of Science ®Google Scholar
• Youinou P., Lydyard P. M. CD5+ B-cells in nonorgan-specific autoimmune diseases: A fresh look. Lupus 2001; 10: 523–525
   PubMedGoogle Scholar
• Zerva L. V., Constantopoulos S. H., Moutsopoulos H. M. Humoral immunity alterations after environmental asbestos exposure. Respiration 1989; 55: 237–241
   PubMed Web of Science ®Google Scholar